Clinical Trials Directory

Trials / Completed

CompletedNCT04124939

Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?

A Randomized Clinical Trial of 100 Units of Intradetrusor Onabotulinum Toxin A for Refractory Overactive Bladder - Is 10 Injections Less Painful Than 20 Injections?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to help determine if 10 injections of Botox ® 100 units is less painful than 20 injections of Botox ® 100 units based on effectiveness in reducing urge incontinence episodes. Study will also be assessed for the pain of procedure and adverse outcomes of 20 injections versus 10 injections.

Detailed description

This study is a randomized clinical trial to assess whether or not 10 injections of 100 units of intradetrusor Botox® toxin is perceived as less painful compared to 20 injections of 100 units of intradetrusor Botox® toxin for the treatment of refractory overactive bladder.

Conditions

Interventions

TypeNameDescription
DRUGOnabotulinumtoxinA 100 UnitsBOTOX for injection is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for: • Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency, in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

Timeline

Start date
2019-11-10
Primary completion
2022-11-09
Completion
2023-02-23
First posted
2019-10-14
Last updated
2024-04-17
Results posted
2023-10-13

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04124939. Inclusion in this directory is not an endorsement.